RBC International Equity Fund OCSE:NOVO B Holdings History
RBC International Equity Fund's Novo Nordisk AS Holding Summary
As of 2025-03-31, RBC International Equity Fund held 10,027.00 shares of Novo Nordisk AS(OCSE:NOVO B), totaling kr685,630.00. This investment constitutes 2.79% of their stock portfolio, and RBC International Equity Fund now holds 0% of the outstanding Novo Nordisk AS(OCSE:NOVO B) stock.
The initial trade took place in 2022Q4. And since then RBC International Equity Fund has made 4 purchases of OCSE:NOVO B, at an average price of kr476.92, for a total of 12,153.00 shares. In addition, there have been 3 sales at an average price of kr688.52 for 2,126.00 shares. Based on historical transaction data and OCSE:NOVO B's current price of kr423.90, RBC International Equity Fund's estimated gain on his OCSE:NOVO B holdings is kr-81,726.04, reflecting a -1.41% gain to date.
RBC International Equity Fund OCSE:NOVO B (kr423.90) Holding Chart
RBC International Equity Fund OCSE:NOVO B (kr423.90) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price kr-/Share | ||
| Shares Sold | 0 | Average Price kr-/Share | ||
| Current Price kr0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
